Zhongnan Medical Journal Press

Home Results

A total of 15 result was found. Results that relate to Breast cancer

Association of p53 codon 72 polymorphism and breast cancer risk in Chinese women: a systematic review and Meta-analysis

Published on New Medicine 2022,32(1):23-32.
3421 times 2117 times

Wen-Bin XU Cheng-Bing GONG Yao LI Guang-Xin ZHONG Xiang SHEN Bin XU Wen-Long JIANG Jiang-Bo LIU

p53 Gene polymorphism Breast cancer Cancer risk Meta-analysis
Details
LncRNA GATA3-AS1 promotes the proliferation and migration of breast cancer cells and the mechanisms underlying its action

Published on New Medicine 2022,32(1):127-137.
4129 times 4245 times

Qi JIANG Yi-Qing XI Lei WEI

LncRNA GATA3-AS1 Breast cancer Proliferation Migration Regulatory mechanism
Details
Progress in research into exosomes in breast cancer microenvironment

Published on New Medicine 2021,31(1):197-203.
6784 times 1721 times

Kang-Di LI Wen-Hua LI

Breast cancer Tumor microenvironment Exosomes
Details
Differentially expressed miRNAs in Luminal and Basal-like breast cancer

Published on New Medicine 2021,31(1):178-185.
7447 times 3089 times

Ming-Juan ZHAO Jiang-Bo LIU Qian-Qian YUAN Tong DENG Qiao HUANG Gao-Song WU Cheng FANG

miRNAs Luminal breast cancer Basal-like breast cancer Survival analysis
Details
Progress of phosphorylated proteomics in breast cancer

Published on New Medicine 2020,30(1):449-456.
6293 times 2244 times

Yu-Jiao DENG Na LI Wen-Ge ZHU Zhi-Jun DAI

Phosphorylated proteomics Breast cancer Carcinogenesis Treatment Prognosis
Details
Correlation analysis of preparatory grief and coping styles in patients with breast cancer

Published on Journal of Mathematical Medicine 2023,36(1):61-67.
1326 times 499 times

Gui-Hua HE Jun-Xia WANG Li-Jiao SHAO

Breast cancer Preparatory grief Coping style
Details
Pathological features of HER-2 hypoexpression breast cancer and its effect on neoad-juvant chemotherapy

Published on Journal of Mathematical Medicine 2023,36(4):282-287.
1510 times 523 times

Jing WANG Nan WANG Xian-Hua QIU

Breast cancer HER-2 Clinicopathological features Neoadjuvant chemotherapy
Details
Survival outcomes after breast-conserving therapy compared with mastectomy for T1-2N0M0 breast cancer patients based on SEER database

Published on New Medicine 2023,33(4):243-251.
2616 times 646 times

Ya-Jing HUANG Wei-Feng SHI

Breast cancer Breast-conserving therapy Mastectomy SEER database
Details
Cost-effectiveness analysis of abemaciclib plus fulvestrant in the second-line treatment for HR﹢/HER2﹣ advanced breast cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1259-1266.
1457 times 524 times

Xi ZHAO Xi YAN Ning LI Chun-Xia HOU

Abemaciclib Fulvestrant Hormone receptor-positive breast cancer Markov model Cost-effectiveness analysis
Details
Study on the curcumin-loaded mesoporous silica nanoparticles modified by polydopamine

Published on Frontiers in Pharmaceutical Sciences 2024,27(4):580-587.
1624 times 462 times

WANG Xiaoning REN Peipei ZHAO Yangguang ZHANG Zhanrui YAN Mengru

Mesoporous silica Polydopamine Curcumin Triple negative breast cancer pH responsive
Details
Efficacy and safety of trastuzumab deruxtecan in the treatment of breast cancer: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):539-548.
1222 times 598 times

ZHANG Xiaoqing LIU Shuai ZHANG Kai LUAN Wei

Trastuzumab deruxtecan Antibody drug conjugates Breast cancer Efficacy Safety Meta-analysis Randomized controlled trial
Details
Progress of clinical research on immunotherapy and antibody-drug conjugates for the treatment of triple-negative breast cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):901-908.
1105 times 366 times

YANG Dan WANG Jinxiu MAO Dahua

Triple-negative breast cancer Immunotherapy Antibody-drug conjugates Clinical trials Immune checkpoint inhibitors Chemotherapy
Details
Construction and validation of a prognostic model for male breast cancer based on the SEER database

Published on New Medicine 2024,34(6):611-621.
974 times 400 times

SU Xiaohan TAN Qiao ZENG Jiao CHENG Panke HOU Lingmi

Male breast cancer Nomogram SEER database Prognosis
Details
CDK4/6 inhibitors in the first-line treatment of HR+/HER2- advanced stage breast cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(9):1017-1029.
882 times 191 times

LI Anna XIA Zhengzheng CAI Jiali LIAN Zhuoshi MENG Jun

CDK4/6 inhibitors Endocrine therapy HR+/HER2- advanced breast cancer Rapid health technology assessment
Details
Efficacy and safety of camrelizumab combined with apatinib in the treatment of triple-negative breast cancer: a Meta-analysis and systematic review

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1137-1146.
428 times 104 times

NIU Zhaofeng ZHAI Yanghai GENG Rui

Camrelizumab Apatinib Triple-negative breast cancer Meta-analysis Systematic review
Details